锝-99m市场规模、份额、增长和趋势分析及2031年预测

  • Report Code : TIPRE00029981
  • Category : Life Sciences
  • No. of Pages : 150
立即购买

锝-99m 市场规模预计将从 2024 年的 46.1 亿美元增长到 2031 年的 62.9 亿美元;预计 2025 年至 2031 年的复合年增长率为 3.9%。

锝-99m市场洞察和分析师观点:

锝-99m是锝-99(锝的同位素)的亚稳态同质异能体。锝-99m是全球医疗诊断程序中最常用的医用放射性同位素之一。推动市场发展的关键因素是慢性病的高发病率和核成像技术的进步。然而,放射性药物的保质期较短阻碍了锝-99m市场的发展。

增长动力和制约因素:

心血管疾病 (CVD)、呼吸系统疾病和癌症等慢性疾病的高发病率将推动单光子发射计算机断层扫描(SPECT) 诊断程序的需求,从而推动锝-99m 市场的增长。根据华盛顿州卫生部的数据,锝-99m 用于与骨骼和心肌相关的诊断程序。它还用于与肺、肝、脾、骨髓、肾、脑、甲状腺、胆囊、唾液腺、心脏血池、感染等​​相关的医学研究。因此,慢性疾病的高发病率将增加锝-99m 在诊断中的应用。

根据美国心脏病学会基金会的数据,心血管疾病相关死亡人数从 1990 年的 1,240 万人增加到 2022 年的 1,980 万人。缺血性心脏病仍然是全球心血管疾病死亡的主要原因。同样,根据国际癌症研究机构 (IARC) 的数据,全球癌症病例的发病率很高。据估计,2020 年全球有 1,930 万例癌症病例,预计到 2040 年病例数将达到约 3,020 万例。此外,世界卫生组织 (WHO) 表示,全球有超过 17.1 亿人患有肌肉骨骼疾病。有效的医学检查对于治疗慢性病至关重要,一些医学影像程序还包括用于诊断和检查目的的核物质。锝-99m和碘-123等放射性药物用于单光子发射计算机断层扫描(SPECT),同样,氟-18和铜-64也用于正电子发射断层扫描(PET)。因此,随着慢性病患病率的激增,医学成像的需求也正在扩大锝-99m的市场规模。

然而,放射性药物的保质期较短阻碍了市场的增长。放射性药物的保质期主要取决于放射性同位素的半衰期、放射化学稳定性以及制剂中放射性核素杂质的浓度。大多数放射性药物制剂含有半衰期很短的放射性同位素。例如,基于锝和 SPECT 的制剂必须在制备后 6 小时内使用。多剂量放射性药物制剂在无菌停用第一剂后的保质期取决于微生物学方面的考虑。在放射性核素半衰期较短的情况下,诊断性放射性药物通常在给患者服用之前在医院放射性药学部门制备。例如,锝-99m 的物理半衰期为 6 小时并且不会在体内停留很长时间。因此,短寿命放射性药物在长期治疗中越来越受到关注,这是制约​​锝-99m市场增长的主要因素。

定制此报告以满足您的要求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

锝-99m市场:

Technetium-99m Market
  • 获取此报告的顶级关键市场趋势。
    此免费样品将包括数据分析,从市场趋势到估计和预测。

报告细分和范围:

锝-99m市场分析基于以下几个细分领域:应用领域和最终用户。根据应用领域,市场细分为心血管、骨扫描、呼吸系统、肿瘤成像等。根据最终用户,市场细分为医院、诊断和影像中心等。锝-99m市场报告涵盖北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东及非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

节段分析:

根据应用领域,锝-99m市场细分为心血管、骨扫描、呼吸系统、肿瘤成像等。心血管领域在2022年占据了锝-99m最大的市场份额。预计骨扫描领域在2022年至2030年期间的复合年增长率最高。

根据最终用户,市场细分为医院、诊断和影像中心以及其他。2022年,诊断和影像中心占据了锝-99m的最大市场份额,预计医院市场在2022年至2030年期间的复合年增长率最高。

区域分析:

从地理上看,全球锝-99m 市场分为五个主要区域:北美、欧洲、亚太、南美和中美以及中东和非洲。

2022 年,北美占据全球最大市场份额。先进医疗基础设施的可用性、主要市场参与者的存在、目标疾病发病率和患病率的上升以及该地区主要参与者推出的产品创新,都可能在未来几年带来新的锝-99m 市场趋势。根据国际癌症研究机构 (IARC) 的数据,预计美国癌症病例数将从 2020 年的 228 万例增加到 2040 年的 312 万例。因此,包括癌症在内的慢性病的增加将刺激对医学成像的需求,从而促进市场增长。此外,美国医疗保险和医疗补助服务中心 (CMS) 根据《临床实验室改进修正案》(CLIA) 采用了与人体实验室研究相关的标准,这有利地提高了锝-99m 市场的表现。

行业发展和未来机遇:

以下列出了全球市场主要参与者采取的一些举措:

  • 2023年11月,国际原子能机构(IAEA)宣布了一项新的协调研究项目(CRP),旨在建立一个由生产商和研究人员组成的全球网络,以开发新一代锝-99m试剂盒和放射性药物。CRP预计将为创新型锝-99m放射性药物的生产、质量控制和临床前测试制定标准流程和指南。CRP还将重点关注最相关的治疗相关物资需求以及创新型放射性标记策略的实施。
  • 2023年2月,BWXT Medical与Laurentis公司合作完成了Tc-99m发生器项目的关键里程碑。Laurentis Energy Partners和BWXT Medical Ltd.已在安大略发电公司(OPG)达灵顿核电站安装并调试了一套创新的同位素系统,使其能够生成钼-99(Mo-99)同位素。钼-99用于生成锝-99亚稳态(Tc-99m),这是核医学中最常用的诊断显像剂之一,有助于检测癌症和心脏病等疾病。达灵顿核电站将成为首个生产钼-99的商业动力反应堆。
  • 2022年2月,Theragnostics宣布其放射诊断成像药物NephroScan(锝99m琥珀酸注射液试剂盒)获得美国FDA批准。NephroScan是用于制备锝99m琥珀酸注射液的专有试剂盒,可用于辅助诊断足月新生儿和成人患者的肾实质疾病。
  • 2021年3月,NorthStar Medical Radioisotopes LLC 和 Ion Beam Applications SA (IBA) 宣布合作,旨在提升全球范围内锝-99m (Tc-99m) 的供应,锝-99m 是应用最广泛的医用放射性同位素。该协议允许美国以外的企业使用 NorthStar 已获专利的非铀基钼-99,该钼-99由 IBA 的加速器和光束线生成。此外,此次合作以现有协议为基础,根据现有协议,IBA 将向 NorthStar 提供最多八台 Rhodotron TT 300-HE 电子束加速器。这有助于非铀基钼-99 的生产,从而使 NorthStar 经 FDA 批准且可商业化使用的 RadioGenix 系统(锝-99m 发生器)能够在美国生产锝-99m。

 

锝-99m市场区域洞察

Insight Partners 的分析师已详尽阐述了预测期内影响锝-99m 市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的锝-99m 市场细分和地域分布。

Technetium-99m Market
  • 获取锝-99m市场的区域特定数据

锝-99m市场报告范围

报告属性细节
2024年的市场规模46.1亿
2031年的市场规模62.9亿
全球复合年增长率(2024-2031)3.9%
史料2021-2023
预测期2025-2031
涵盖的领域按应用领域
  • 心血管
  • 骨扫描
  • 呼吸系统
  • 肿瘤成像
按最终用户
  • 医院
  • 诊断和影像中心
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 兰瑟斯医学成像公司
  • 朱比兰特制药公司
  • 北极星医疗放射性同位素有限责任公司
  • 太阳制药工业公司
  • 推进核医学
  • NTP放射性同位素SOC有限公司
  • 西北医学同位素有限责任公司
  • SHINE技术有限公司
  • 康德乐

 

锝-99m市场参与者密度:了解其对商业动态的影响

锝-99m市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的不断变化、技术进步以及对产品优势的认知度不断提高。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。

市场参与者密度是指特定市场或行业内企业或公司的分布情况。它表明特定市场空间内竞争对手(市场参与者)的数量相对于其规模或总市值而言。

在锝-99m 市场运营的主要公司有:

  1. 兰瑟斯医学成像公司
  2. 朱比兰特制药公司
  3. 北极星医疗放射性同位素有限责任公司
  4. 太阳制药工业公司
  5. 推进核医学

免责声明以上列出的公司没有按照任何特定顺序排列。


Technetium-99m Market

 

  • 获取锝-99m 市场顶级关键参与者概览

竞争格局和重点公司:

Lantheus Medical Imaging Inc、Curium、Jubilant Pharma Company、NorthStar Medical Radioisotopes LLC、Sun Pharmaceutical Industries Inc、Advancing Nuclear Medicine、NTP Radioisotopes SOC Ltd、Northwest Medical Isotopes LLC、SHINE Technologies LLC 和 Cardinal Health 是锝-99m 市场报告中介绍的知名企业。这些公司专注于新技术、现有产品的改进和地域扩张,以满足全球日益增长的消费者需求,并扩大其专业产品组合的范围。

  • 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
  • PEST 和 SWOT 分析
  • 市场规模价值/数量 - 全球、区域、国家
  • 行业和竞争格局
  • Excel 数据集
technetium-99m-market-report-deliverables-img1
technetium-99m-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

常见问题


What are the growth estimates for the technetium-99m market till 2031?

The technetium-99m market is expected to be valued at US$ 6.29 billion in 2031.

Which application area segment dominates the technetium-99m market?

Based on application area, the technetium-99m market is segmented into cardiovascular, bone scan, respiratory, tumor imaging, and others. The cardiovascular segment held the largest technetium-99m market share in 2022. The bone scan segment is anticipated to register the highest CAGR during 2022–2030.

Which end user segment dominates the technetium-99m market?

Based on end user, the market is segmented into hospitals, diagnostic and imaging centers, and others. In 2022, the diagnostic and imaging centers segment held the largest technetium-99m market share, and the hospitals segment is anticipated to register the highest CAGR during 2022–2030.

What factors drive the technetium-99m market?

Key factors driving the market are the high prevalence of chronic diseases and advancements in nuclear imaging techniques.

What was the estimated technetium-99m market size in 2024?

The technetium-99m market was valued at US$ 4.61 billion in 2022.

What is technetium-99m?

Technetium-99m is a metastable nuclear isomer of technetium-99, an isotope of technetium. Technetium-99m is among the most commonly used medical radioisotopes in medical diagnostic procedures globally.

Who are the major players in the technetium-99m market?

The technetium-99m market majorly consists of the players, including Lantheus Medical Imaging Inc, Curium, Jubilant Pharma Company, NorthStar Medical Radioisotopes LLC, Sun Pharmaceutical Industries Inc, Advancing Nuclear Medicine, NTP Radioisotopes SOC Ltd, Northwest Medical Isotopes LLC, SHINE Technologies LLC, and Cardinal Health.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Technetium-99m Market

  1. Lantheus Medical Imaging Inc
  2. Curium
  3. Jubilant Pharma Company
  4. NorthStar Medical Radioisotopes LLC
  5. Sun Pharmaceutical Industries Inc
  6. Advancing Nuclear Medicine
  7. NTP Radioisotopes SOC Ltd
  8. Northwest Medical Isotopes LLC
  9. SHINE Technologies LLC
  10. Cardinal Health
technetium-99m-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.